On behalf of the Board of Directors of Cengild Medical, UOB Kay Hian (M) Sdn Bhd wishes to announce that the Company proposes to undertake the Proposed Strategic Equity Participation Plan through placement of up to 16,658,252 new ordinary shares in Cengild Medical, representing up to 2% of the total number of issued Cengild Medical Shares, to the eligible medical consultants ("Consultant(s)") to be identified, at an issue price to be determined at a later date in accordance with the general mandate pursuant to Sections 75 and 76 of the Act.

The Proposed Strategic Equity Participation Plan is intended to provide the Consultants, being specialist medical practitioners who have established professional relationships with Cengild Medical and its subsidiary ("Cengild Medical Group" or the "Group") with an opportunity to participate in the equity and future growth of the Group. These Consultants play an integral role in supporting the Group's clinical capabilities, breadth of specialist medical services and overall development. The Proposed Strategic Equity Participation Plan forms part of the Group's broader strategy to enhance the Group's ability to attract and retain experienced medical specialists, and encourage their continued commitment and contribution to the Group's long-term growth and value creation.

Further details of the Proposed Strategic Equity Participation Plan are set out in the attachment below.

This announcement is dated 7 September 2026.